Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action
- 1 June 2002
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 35 (6) , 1204-1209
- https://doi.org/10.1067/mva.2002.122027
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirinAmerican Heart Journal, 2000
- Ticlopidine and ClopidogrelCirculation, 1999
- Comparative Safety and Tolerability of Clopidogrel and AspirinDrug Safety, 1999
- Transcranial doppler microembolus detection in the identification of patients at high risk of perioperative strokeEuropean Journal of Vascular and Endovascular Surgery, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- A comparison of quality control methods applied to carotid endarterectomyEuropean Journal of Vascular and Endovascular Surgery, 1996
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991